{"description":"All participants who received at least one dose of the trial medication and had at least one safety follow-up, whether withdrawn prematurely or not, were included in the safety analysis population (SAP).","eventGroups":[{"description":"Participants received either Alimta 500 mg/m\\^2 every 21 days until disease progression, unacceptable toxicity or death or Taxotere 75 mg/m\\^2 every 3 weeks until disease progression, unacceptable toxicity or death. Choice of comparator was left to the discretion of the investigator in countries where both treatments are registered to use and are commercially available for second line use (otherwise, Taxotere was administered), assigning the participant to either comparator depending upon the medical needs of the participant. Participants were required to receive concomitant treatment therapy as indicated in the product label.","id":"EG000","otherNumAffected":106,"otherNumAtRisk":213,"seriousNumAffected":31,"seriousNumAtRisk":213,"title":"Comparator"},{"description":"Participants received a single oral dose of erlotinib 150 mg/day until disease progression, unacceptable toxicity or death.","id":"EG001","otherNumAffected":125,"otherNumAtRisk":196,"seriousNumAffected":20,"seriousNumAtRisk":196,"title":"Erlotinib"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":213},{"groupId":"EG001","numAffected":74,"numAtRisk":196}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Alopecia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":12,"numAtRisk":196}],"term":"Dermatitis acneiform"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":11,"numAtRisk":196}],"term":"Acne"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":213},{"groupId":"EG001","numAffected":37,"numAtRisk":196}],"term":"Diarrhoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":29,"numAtRisk":213},{"groupId":"EG001","numAffected":15,"numAtRisk":196}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":213},{"groupId":"EG001","numAffected":13,"numAtRisk":196}],"term":"Asthenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":213},{"groupId":"EG001","numAffected":9,"numAtRisk":196}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":213},{"groupId":"EG001","numAffected":10,"numAtRisk":196}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":213},{"groupId":"EG001","numAffected":10,"numAtRisk":196}],"term":"Chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":213},{"groupId":"EG001","numAffected":3,"numAtRisk":196}],"term":"Oedema peripheral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":213},{"groupId":"EG001","numAffected":20,"numAtRisk":196}],"term":"Dyspnoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":213},{"groupId":"EG001","numAffected":15,"numAtRisk":196}],"term":"Cough"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":213},{"groupId":"EG001","numAffected":17,"numAtRisk":196}],"term":"Decreased appetite"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":213},{"groupId":"EG001","numAffected":4,"numAtRisk":196}],"term":"Anaemia"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":4,"numAtRisk":196}],"term":"Pulmonary embolism"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Haemoptysis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Chronic obstructive pulmonary disease"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Pulmonary effusion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Pneumothorax"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Pulmonary haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Back pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Abdominal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Enterocolitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Gastric perforation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Oesophagitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Proctitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Subileus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Upper gastrointestinal haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Anaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Febrile neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Pancytopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Thrombocytopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Erysipelas"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Gastroenteritis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Lower respiratory tract infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Pharyngitis bacterial"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Death"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Venous thrombosis limb"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Deep vein thrombosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Vena cava thrombosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Supraventricular tachycardia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Cardiac failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Renal failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Hypercalcaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Narcotic intoxication"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Vascular access complication"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Cerebrovascular accident"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":213},{"groupId":"EG001","numAffected":0,"numAtRisk":196}],"term":"Ischaemic stroke"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (13.0)","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":213},{"groupId":"EG001","numAffected":1,"numAtRisk":196}],"term":"Spinal cord compression"}],"timeFrame":"All adverse events (related and unrelated) occurring during the study and for up to 28 days after the last dose of study medication were reported."}